Minimally Invasive Gastrointestinal Surgical Systems Market is anticipated to reach $10,441.0 million by 2031

The global minimally invasive gastrointestinal surgical systems market was valued at $5,021.8 million in 2020 and is anticipated to reach $10,441.0 million by 2031, growing at a CAGR of 6.8% during the forecast period 2021-2031.

Factors that can boost the growth of the market include advantages of minimally invasive surgical procedures over conventional open surgical procedures, availability of technological advanced products in the field of GI surgical procedures, increasing healthcare spending, and growth in robotics GI surgical procedures.

Surgeries for which minimally invasive gastrointestinal surgical systems can be used include Adrenalectomy, Appendectomy, Bariatric Surgery, Cholecystectomy, Colon and Rectal Surgery, Foregut Surgery, and Hernia Repair. End-users that use minimally invasive gastrointestinal surgical systems include hospitals, ambulatory surgical centers, and specialty clinics.

Key players operating in the market include Ambu A/S, B. Braun Melsungen AG, Boston Scientific Corporation, Conmed Corporation, Cook Medical Inc., Intuitive Surgical, Inc., Olympus Corporation, Medtronic plc, Karl Storz SE & Co. KG, Stryker Corporation, Schölly Fiberoptic GmbH, Xenocor Inc., Fujifilm Holdings Corporation, Pentax Medical (Hoya Corporation), Richard Wolf GmbH, and TransEnterix, Inc.

Growth Drivers

• Advantages of Minimally Invasive Surgical Procedures Over Conventional Open Surgical Procedures

• Availability of Technological Advanced Products in the Field of GI Surgical Procedures

• Increasing Healthcare Spending

• Growth in Robotics GI Surgical Procedures

Market Challenges

• High Cost of Minimally Invasive GI Surgical Procedures

• Shortage of Skilled Professionals

• Restrictive Reimbursement Framework

Market Opportunities

• Development of Long-Distance Teleoperated Surgical Robotic Systems

• Mergers and Acquisitions to Diversify Endoscopic Portfolio

• Investment for Regional Expansion

Key Questions Answered in this Report:

•   What is the current market size and future potential of these products?
•   What is the current market share and growth share of the different products in the market?
•   What are the guidelines implemented by different government bodies to regulate the approval of minimally invasive gastrointestinal surgical systems?
•   What are the major market drivers, restraints, and opportunities in the global minimally invasive gastrointestinal surgical systems market?
•   What is the impact of the COVID-19 pandemic on the market?
•   Which technology is being researched and worked upon to improve the gastrointestinal surgical systems?
•   Who are the leading players dominating the global minimally invasive gastrointestinal surgical systems market?
•   What are the key development and strategies incorporated by the players of global minimally invasive gastrointestinal surgical systems market, to sustain the competition and retain their supremacy?
•   Which countries contribute to the major share of current demand and which countries hold significant scope for expansion for business activities, by players of the global minimally invasive gastrointestinal surgical systems market?
•   How advanced technologies such as surgical robotics is gaining traction in terms of market share in in gastrointestinal space?

Request a Sample - https://bisresearch.com/requestsample?id=1072&type=download

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing microbiome therapeutics market is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Digital PCR Market size,Share, Leading Players, Growth, Development and Demand Forecast to 2032

Increasing investments in R&D for d-PCR molecular diagnostics is one of the major opportunities in the global digital PCR market. Several biotechnology and life sciences companies are working collaboratively on diagnostic test development and using d-PCR as a therapeutic means for applications in several disease indications to enable efficient diagnosis, treatment selection, and treatment monitoring. The global digital PCR market is projected to reach $2,847.8 million by 2032 from $441.2 million in 2021, at a CAGR of 18.73% during the forecast period 2022–2032. The growth in the global digital PCR market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases globally, the rising awareness of d-PCR-based diagnostic testing, and the significant number of funding for executing research and development. Impact of COVID-19 The current global digital PCR market comprises kits and assays, system, and reagents and consuma...

Radiation Dose Management Market Likely To Increase Size, Shares, And Demand Forecast 2022-2032

Radiation dose is the amount of radiation absorbed by a patient during a diagnostic imaging procedure. A large dose of radiation can cause tissue damage and increase the risk of developing cancer in later stages of life.The development of on-cloud dose management solutions and the growing initiatives on radiation dose management for pediatric procedures are some of the major opportunities in the global radiation dose management market. Furthermore, some of the key trends going on in the market include the increasing development of imaging modalities with technologies that lower radiation dose, partnerships and strategic business alliances dominating the market, and various collaborations among market players. The global radiation dose management market was valued at $212.8 million in 2021 and is anticipated to reach $586.7 million by 2032, witnessing a CAGR of 10.30% during the forecast period 2022–2032. The growth in the global radiation dose management market is ex...

Market Research Reports

Search This Blog